Literature DB >> 21074608

The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo.

Javier I Ottaviani1, Tony Y Momma, Christian Heiss, Catherine Kwik-Uribe, Hagen Schroeter, Carl L Keen.   

Abstract

Extensive epidemiological and clinical evidence associates diets high in flavanol-containing foods with cardiovascular health benefits in humans. Catechin and epicatechin, the most common flavanols in foods, are present in the diet in different enantiomeric forms. This study investigated the influence of the stereochemical configuration of flavanols on their absorption, metabolism, and biological activity. Healthy adult males were asked to consume equal amounts of the stereochemically pure flavanols (-)-epicatechin, (-)-catechin, (+)-catechin, and (+)-epicatechin (1.5mg/kg bw) in a well-defined cocoa-based, dairy-containing drink matrix, and flavanol levels were subsequently determined in plasma and 24-h urine. The results obtained show that the stereochemical configuration of flavanols has a profound influence on their uptake and metabolism in humans. In addition, we assessed the vasodilatory activity of each flavanol stereoisomer in vivo and found (-)-epicatechin to be the single stereoisomer capable of mediating a significant arterial dilation response. Importantly, this effect was independent of the classic antioxidant properties of flavanols. Overall, these results indicate that the proposed beneficial health effects associated with the consumption of flavanol-containing foods will significantly depend on the stereochemical configuration of the flavanols ingested.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074608     DOI: 10.1016/j.freeradbiomed.2010.11.005

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  35 in total

1.  (-)-Epicatechin prevents TNFα-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes.

Authors:  Marcela A Vazquez-Prieto; Ahmed Bettaieb; Fawaz G Haj; César G Fraga; Patricia I Oteiza
Journal:  Arch Biochem Biophys       Date:  2012-03-08       Impact factor: 4.013

2.  A pilot study on clinical pharmacokinetics and preclinical pharmacodynamics of (+)-epicatechin on cardiometabolic endpoints.

Authors:  Aldo Moreno-Ulloa; Nayelli Nájera-García; Marcela Hernández; Israel Ramírez-Sánchez; Pam R Taub; Yongxuan Su; Ernesto Beltrán-Partida; Guillermo Ceballos; Sundeep Dugar; George Schreiner; Brookie M Best; Theodore P Ciaraldi; Robert R Henry; Francisco Villarreal
Journal:  Food Funct       Date:  2018-01-24       Impact factor: 5.396

Review 3.  Cocoa Flavanol Supplementation and Exercise: A Systematic Review.

Authors:  Lieselot Decroix; Danusa Dias Soares; Romain Meeusen; Elsa Heyman; Cajsa Tonoli
Journal:  Sports Med       Date:  2018-04       Impact factor: 11.136

4.  (-)-Epicatechin administration and exercising skeletal muscle vascular control and microvascular oxygenation in healthy rats.

Authors:  Steven W Copp; Tadakatsu Inagaki; Michael J White; Daniel M Hirai; Scott K Ferguson; Clark T Holdsworth; Gabrielle E Sims; David C Poole; Timothy I Musch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-09       Impact factor: 4.733

Review 5.  Bioavailability of bioactive food compounds: a challenging journey to bioefficacy.

Authors:  Maarit J Rein; Mathieu Renouf; Cristina Cruz-Hernandez; Lucas Actis-Goretta; Sagar K Thakkar; Marcia da Silva Pinto
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

6.  (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle.

Authors:  Leonardo Nogueira; Israel Ramirez-Sanchez; Guy A Perkins; Anne Murphy; Pam R Taub; Guillermo Ceballos; Francisco J Villarreal; Michael C Hogan; Moh H Malek
Journal:  J Physiol       Date:  2011-07-25       Impact factor: 5.182

7.  Synthesis of novel (-)-epicatechin derivatives as potential endothelial GPER agonists: Evaluation of biological effects.

Authors:  Viviana Sarmiento; Israel Ramirez-Sanchez; Aldo Moreno-Ulloa; Diego Romero-Perez; Daniel Chávez; Miguel Ortiz; Nayelli Najera; Jose Correa-Basurto; Francisco Villarreal; Guillermo Ceballos
Journal:  Bioorg Med Chem Lett       Date:  2018-01-24       Impact factor: 2.823

8.  (-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress.

Authors:  Ahmed Bettaieb; Marcela A Vazquez Prieto; Cecilia Rodriguez Lanzi; Roberto M Miatello; Fawaz G Haj; César G Fraga; Patricia I Oteiza
Journal:  Free Radic Biol Med       Date:  2014-04-16       Impact factor: 7.376

9.  (-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients.

Authors:  Israel Ramirez-Sanchez; Pam R Taub; Theodore P Ciaraldi; Leonardo Nogueira; Taylor Coe; Guy Perkins; Michael Hogan; Alan S Maisel; Robert R Henry; Guillermo Ceballos; Francisco Villarreal
Journal:  Int J Cardiol       Date:  2013-07-17       Impact factor: 4.164

10.  Stimulatory effects of the flavanol (-)-epicatechin on cardiac angiogenesis: additive effects with exercise.

Authors:  Israel Ramirez-Sanchez; Leonardo Nogueira; Aldo Moreno; Ann Murphy; Pam Taub; Guy Perkins; Guillermo M Ceballos; Michael Hogan; Moh Malek; Francisco Villarreal
Journal:  J Cardiovasc Pharmacol       Date:  2012-11       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.